PARAGANGLIOMA
Clinical trials for PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug tested as last hope for rare, Tough-to-Treat cancers
Disease control TerminatedThis study tested whether a drug called SGI-110 could shrink or slow the growth of certain rare cancers, including specific types of stomach, adrenal, and kidney tumors. It was for patients aged 12 and older whose cancers had not responded to standard treatments. Participants rec…
Matched conditions: PARAGANGLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Experimental vaccine fights rare adrenal cancers
Disease control TerminatedThis study tested a new cancer vaccine called EO2401 combined with an immunotherapy drug for people with advanced adrenal cancers that had spread. The goal was to see if this combination was safe and could help control these rare, aggressive tumors. The trial enrolled 70 adults w…
Matched conditions: PARAGANGLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC